EGFR-Targeted Photodynamic Therapy
Luca Ulfo1, Paolo Emidio Costantini1, Matteo Di Giosia2
1Dipartimento di Farmacia e Biotecnologie, Alma Mater Studiorum-Università di Bologna, Via Francesco Selmi 3, 40126 Bologna, Italy.
Abstract:
The epidermal growth factor receptor (EGFR) plays a pivotal role in the proliferation and metastatization of cancer cells. Aberrancies in the expression and activation of EGFR are hallmarks of many human malignancies. As such, EGFR-targeted therapies hold significant potential for the cure of cancers. In recent years, photodynamic therapy (PDT) has gained increased interest as a non-invasive cancer treatment. In PDT, a photosensitizer is excited by light to produce reactive oxygen species, resulting in local cytotoxicity. One of the critical aspects of PDT is to selectively transport enough photosensitizers to the tumors environment. Accordingly, an increasing number of strategies have been devised to foster EGFR-targeted PDT. Herein, we review the recent nanobiotechnological advancements that combine the promise of PDT with EGFR-targeted molecular cancer therapy. We recapitulate the chemistry of the sensitizers and their modes of action in PDT, and summarize the advantages and pitfalls of different targeting moieties, highlighting future perspectives for EGFR-targeted photodynamic treatment of cancer.
Insights
Epidermal growth factor receptor (EGFR)-targeted photodynamic therapy (PDT) shows promise for cancer treatment. Nanobiotechnology enhances photosensitizer delivery for improved efficacy in EGFR-driven cancers.
Area of Science:
- Oncology
- Nanotechnology
- Biochemistry
Background:
- Epidermal growth factor receptor (EGFR) is crucial in cancer proliferation and metastasis.
- Aberrant EGFR expression and activation are common in human malignancies.
- EGFR-targeted therapies offer significant potential for cancer treatment.
Purpose of the Study:
- To review nanobiotechnological advancements in EGFR-targeted photodynamic therapy (PDT).
- To explore strategies for selective photosensitizer delivery to tumors.
- To summarize the chemistry, action, and targeting moieties of PDT sensitizers.
Main Methods:
- Review of recent nanobiotechnological strategies for EGFR-targeted PDT.
- Recapitulation of photosensitizer chemistry and mechanisms of action.
- Summary of advantages and disadvantages of various targeting strategies.
Main Results:
- Nanobiotechnology offers promising approaches for EGFR-targeted PDT.
- Selective delivery of photosensitizers to tumors is critical for PDT efficacy.
- Various targeting moieties have different benefits and drawbacks.
Conclusions:
- EGFR-targeted PDT, enhanced by nanobiotechnology, represents a promising non-invasive cancer treatment.
- Further research into targeting moieties and delivery systems is needed.
- This approach holds potential for future cancer therapy.
